Roche’s Accu-Chek Connect Diabetes Management App has hit yet another snag with the FDA. On February 15, the agency issued a Class 2 Device Recall for certain software versions of the app due to a bug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback